Global Elastomeric Infusion Pumps Market Size by Type (Continuous, Variable Rate Elastomeric Pumps), by Application (Pain Management, Antibiotic/Antiviral, Chemotherapy) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Medical Devices
  • |
  • ID : 1261465
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Elastomeric infusion pumps are used for the administration of liquid drugs such as analgesics, local anesthetics, antibiotics, or cytostatics, based on the treatment therapy. The required pressure to administer the drug is generated from the balloon/elastomeric layer that is molded inside elastomeric infusion pumps. This layer is stretched when elastomeric infusion pumps are filled. The elastic constriction leads the liquid via tubing and gradually through a flow restrictor out into the patient connection.

The global elastomeric infusion pumps market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The Elastomeric Infusion Pumps Market is primarily driven by growing demand of infusion pumps in chelation therapy, antibiotic therapy and antivirals therapy. However, high cost of treatment and side effects of analgesia are the major factors expected to hamper the growth of the global market.

The global elastomeric infusion pumps market is primarily segmented based on different type, application and regions. On the basis of type, the market is divided continuous rate elastomeric pumps, variable rate elastomeric pumps and others. Depending on application, it is categorized into pain management, antibiotic/antiviral, chemotherapy and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of type, the market is split into:
* Continuous Rate Elastomeric Pumps
* Variable Rate Elastomeric Pumps
* Others

On the basis of application, the market is split into:
* Pain Management
* Antibiotic/Antiviral
* Chemotherapy
* Others

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Baxter International, Inc.
* Fresenius Kabi AG
* B. Braun Melsungen AG
* Ambu A/S
* Leventon, S.A.U.
* Nipro Corporation
* Terumo Corporation
* Avanos Medical, Inc.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type and application market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, type and application with qualitative and quantitative information and facts

Target Audience:
* Elastomeric Infusion Pumps Manufacturer
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Elastomeric Infusion Pumps Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Elastomeric Infusion Pumps Market - Porter\'s Five Forces Analysis
4.4. Global Elastomeric Infusion Pumps Market - PESTEL Analysis

5. Global Elastomeric Infusion Pumps Market, by Type
5.1. Global Elastomeric Infusion Pumps Market, Size and Forecast, 2015-2026
5.2. Global Elastomeric Infusion Pumps Market, by Continuous Rate Elastomeric Pumps, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Elastomeric Infusion Pumps Market, by Variable Rate Elastomeric Pumps, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Elastomeric Infusion Pumps Market, by Others, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026

6. Global Elastomeric Infusion Pumps Market, by Application
6.1. Global Elastomeric Infusion Pumps Market, Size and Forecast, 2015-2026
6.2. Global Elastomeric Infusion Pumps Market, by Pain Management, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Elastomeric Infusion Pumps Market, by Antibiotic/Antiviral, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Elastomeric Infusion Pumps Market, by Chemotherapy, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Elastomeric Infusion Pumps Market, by Others, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Elastomeric Infusion Pumps Market, by Region
7.1. Elastomeric Infusion Pumps Market Regional Analysis, 2015-2026
7.2. Global Elastomeric Infusion Pumps Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Elastomeric Infusion Pumps Market, 2015-2026
7.3.1. North America Elastomeric Infusion Pumps Market Size and Forecast, 2015-2026
7.3.2. North America Elastomeric Infusion Pumps Market by Country, 2015-2026
7.3.2.1. U.S. Elastomeric Infusion Pumps Market, 2015-2026
7.3.2.2. Canada Elastomeric Infusion Pumps Market, 2015-2026
7.4. Europe Elastomeric Infusion Pumps Market, 2015-2026
7.4.1. Europe Elastomeric Infusion Pumps Market Size and Forecast, 2015-2026
7.4.2. Europe Elastomeric Infusion Pumps Market by Country, 2015-2026
7.4.2.1. Germany Elastomeric Infusion Pumps Market, 2015-2026
7.4.2.2. France Elastomeric Infusion Pumps Market, 2015-2026
7.4.2.3. Italy Elastomeric Infusion Pumps Market, 2015-2026
7.4.2.4. UK Elastomeric Infusion Pumps Market, 2015-2026
7.4.2.5. Spain Elastomeric Infusion Pumps Market, 2015-2026
7.4.2.6. Rest of Europe Elastomeric Infusion Pumps Market, 2015-2026
7.5. Asia Pacific Elastomeric Infusion Pumps Market, 2015-2026
7.5.1. Asia Pacific Elastomeric Infusion Pumps Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Elastomeric Infusion Pumps Market by Country, 2015-2026
7.5.2.1. Japan Elastomeric Infusion Pumps Market, 2015-2026
7.5.2.2. China Elastomeric Infusion Pumps Market, 2015-2026
7.5.2.3. India Elastomeric Infusion Pumps Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Elastomeric Infusion Pumps Market, 2015-2026
7.6. South America Elastomeric Infusion Pumps Market, 2015-2026
7.6.1. South America Elastomeric Infusion Pumps Market Size and Forecast, 2015-2026
7.6.2. South America Elastomeric Infusion Pumps Market by Country, 2015-2026
7.6.2.1. Mexico Elastomeric Infusion Pumps Market, 2015-2026
7.6.2.2. Brazil Elastomeric Infusion Pumps Market, 2015-2026
7.6.2.3. Rest of South America Elastomeric Infusion Pumps Market, 2015-2026
7.7. Middle East & Africa Elastomeric Infusion Pumps Market, 2015-2026
7.7.1. Middle East & Africa Elastomeric Infusion Pumps Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Elastomeric Infusion Pumps Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Elastomeric Infusion Pumps Market, 2015-2026
7.7.2.2. South Africa Elastomeric Infusion Pumps Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Elastomeric Infusion Pumps Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Baxter International, Inc.
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Fresenius Kabi AG
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Braun Melsungen AG
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Ambu A/S
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Leventon, S.A.U.
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Nipro Corporation
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Terumo Corporation
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Avanos Medical, Inc.
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
10. Key Insights

Content are not available

Choose License Type